Yoshiyuki Abe
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Co-authors
- Masato NakamuraYoshito UeyamaHiroshi KijimaNorikazu TamaokiH. YamazakiY OshikaHiroyuki HatanakaHitoshi Yamazaki
- Topics
- Angiogenesis and VEGF in Cancer (21 papers)Vasculitis and related conditions (11 papers)Drug Transport and Resistance Mechanisms (10 papers)
In The Last Decade
Yoshiyuki Abe
128 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.4k
- Oncology 1.0k
- Cancer Research 741
- Pulmonary and Respiratory Medicine 512
- Immunology 419
Countries citing papers authored by Yoshiyuki Abe
This map shows the geographic impact of Yoshiyuki Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Abe more than expected).
Fields of papers citing papers by Yoshiyuki Abe
This network shows the impact of papers produced by Yoshiyuki Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Abe. The network helps show where Yoshiyuki Abe may publish in the future.
Co-authorship network of co-authors of Yoshiyuki Abe
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyuki Abe. A scholar is included among the top collaborators of Yoshiyuki Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyuki Abe. Yoshiyuki Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 16 | |
| 9 | 11 | |
| 10 | 187 | |
| 11 | 108 | |
| 12 | Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme. | 12 |
| 13 | Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. | 46 |
| 14 | [Clinicopathological study of pulmonary hamartoma with special reference to 6 patients who also had another tumor]. | 0 |
| 15 | 26 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 3 | |
| 19 | 1 | |
| 20 | 0 |
About Yoshiyuki Abe
Yoshiyuki Abe is a scholar working on Rheumatology, Oncology and Cancer Research, having authored 137 papers that have together received 2.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (21 papers), Vasculitis and related conditions (11 papers) and Drug Transport and Resistance Mechanisms (10 papers). The work is most often cited by research in Cancer Research (741 citations), Oncology (1.0k citations) and Immunology and Allergy (143 citations). Yoshiyuki Abe has collaborated with scholars based in Japan, Canada and Czechia. Frequent co-authors include Masato Nakamura, Yoshito Ueyama, Hiroshi Kijima, Norikazu Tamaoki, H. Yamazaki, Y Oshika, Hiroyuki Hatanaka, Hitoshi Yamazaki, Tetsuji Tokunaga and T Tokunaga. Their work appears in journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.